Cleared Traditional

K011082 - TPO IGG ANTIBODY EIA TEST
(FDA 510(k) Clearance)

Jun 2001
Decision
57d
Days
Class 2
Risk

K011082 is an FDA 510(k) clearance for the TPO IGG ANTIBODY EIA TEST. This device is classified as a System, Test, Thyroid Autoantibody (Class II - Special Controls, product code JZO).

Submitted by Scimedx Corp. (Denvill, US). The FDA issued a Cleared decision on June 6, 2001, 57 days after receiving the submission on April 10, 2001.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5870.

Submission Details

510(k) Number K011082 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2001
Decision Date June 06, 2001
Days to Decision 57 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code JZO — System, Test, Thyroid Autoantibody
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5870

Similar Devices — JZO System, Test, Thyroid Autoantibody

All 91
ADVIA Centaur Anti-Thyroid Peroxidase II
K250250 · Siemens Healthcare Diagnostics, Inc. · Oct 2025
Access TPO Antibody
K240469 · Beckman Coulter, Inc. · Aug 2024
Access Thyroglobulin Antibody II
K213517 · Beckman Coulter, Inc. · Sep 2023
Elecsys Anti-Tg
K222610 · Roche Diagnostics · Sep 2023
Elecsys Anti-TSHR
K193313 · Roche Diagnostics · Feb 2020
EliA anti-TG Immunoassay, EliA anti-TPO Immunoassay, EliA Thyroid Positive Control 250, EliA Thyroid Positive Control 2500/5000
K151799 · Phadia AB · Mar 2016